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Abstract Our environment poses a constant threat to our
health. To survive, all organisms must be able to dis-
criminate between good (food ingredients and microbes
that help digest our food) and bad (pathogenic microbes,
viruses and toxins). In vertebrates, discrimination between
beneficial and harmful antigens mainly occurs at the mu-
cosal surfaces of the respiratory, digestive, urinary and
genital tract. Here, an extensive network of cells and or-
gans form the basis of what we have come to know as the
mucosal immune system. The mucosal immune system is
composed of a single epithelial cell layer protected by a
mucus layer. Different immune cells monitor the baso-
lateral side of the epithelial cells and dispersed secondary
lymphoid organs, such as Peyer’s patches and isolated
lymphoid follicles are equipped with immune cells able to
mount appropriate and specific responses. This review will
focus on the current knowledge on host, dietary and bac-
terial-derived factors that shape the mucosal immune
system before and after birth. We will discuss current
knowledge on fetal immunity (both responsiveness and
lymphoid organ development) as well as the impact of diet
and microbial colonization on neonatal immunity and
disease susceptibility. Lastly, inflammatory bowel disease
will be discussed as an example of how the composition of
the microbiota might predispose to disease later in life. A
fundamental understanding of the mechanisms involved in
mucosal immune development and tolerance will aid
nutritional intervention strategies to improve health in
neonatal and adult life.
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Previously it was thought that the fetal environment in the
uterus was sterile and the fetal immune system was im-
mature and inactive. However, in recent years, more and
more evidence has emerged that the fetus is actually ex-
posed to environmental antigens prior to birth and that the
contact between the immune system of mother and child is
far more intimate than previously thought. Here, we will
summarize the most recent data (see also Table 1).
For example, bacteria belonging to the genus of
Enterococcus, Streptococcus, Staphylococcus, and Propi-
onibacterium could be cultured from umbilical cord blood
of healthy neonates born by cesarian section (Jimenez et al.
2005). Additionally, while cultivation of the placental
samples did not reveal the presence of viable bacteria,
Bifidobacterium and Lactobacillus DNA could be detected
in 33 and 31 of 34 placenta samples, respectively (Satokari
et al. 2009). In a recent study, 320 placental samples were
analyzed by comparative 16S ribosomal DNA-based and
whole-genome shotgun metagenomics. Here, the authors
report that the placenta harbors a unique microbiome
consisting of several non-pathogenic bacteria. This pla-
cental microbiome mostly resembled the mother’s oral
microbiome (Aagaard et al. 2014). The placenta, therefore,
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Table 1 Environmental factors influencing host immunity during fetal and neonatal life






APCs epigenetically regulate RORct
expression in umbilical cord T cells
Human (de Roock et al. 2013; Stoppelenburg et al. 2014)
Microbial-derived
riboflavins
Fetal intestinal MAIT cells produce
IFN and IL-22
Human (Corbett et al. 2014; Kjer-Nielsen et al. 2012; Le









Preventing TLR signaling Human (Kim et al. 2002)
EGF Preventing TLR signaling Human (Good et al. 2012)
Maternal
factors
Cells that cross the
placenta
Induction Tregs in secondary lymphoid
tissue
Human (Mold et al. 2008)
Consumed
vegetables
Less intraepithelial lymphocytes and
RORct? ILCs




Altered TLR expression in exfoliated
cells





Breast milk Growth factors Increased epithelial barrier functioning Human (Wagner et al. 2008)
Lactoferrin Anti-microbial Human (de Oliveira et al. 2001; Giugliano et al. 1995)




(Oozeer et al. 2013; Scholz-Ahrens et al. 2007;
Scholz-Ahrens and Schrezenmeir 2007)





Wound healing and tissue repair Rats (Clark et al. 2006; Halpern et al. 2003)
Epidermal growth
factors
Anti-inflammatory and induced mucus
production
Rats (Clark et al. 2006; Halpern et al. 2003)








bIgG Recognizes pathogens that can also
infect humans (e.g. RSV)
Human (den Hartog et al. 2014)
Collostrum bIgG Reduces recurrent diarrhea in AIDS
patients




Protects low birth weight infants from
necrotizing enterocolitis
Human (Manzoni et al. 2014)
Vitamin A Establishes normal levels of type 3
(RORcT?) intestinal lymphoid cells
Mice (Spencer et al. 2014)
Retinoic acid
(? TGF-b)
Promotion of Tregs via CD103? DCs Human/
mice
(Coombes et al. 2007; den Hartog et al. 2013)
Retinoic acid Inhibits Th17/converts Tregs to T
follicular helper cells/upreg. CCR9
and a4b7
Mice (Benson et al. 2007; Iwata et al. 2004; Mora et al.
2003; Mucida et al. 2007; Sun et al. 2007;
Takahashi et al. 2012)
Retinoic acid Induce IgA-secreting B cells Human/
mice
(Mora et al. 2006)
miR-10a induced by
retinoic acid
T-bet expression/Th1 immunity Mice (Takahashi et al. 2012)
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might harbor several antigens to which the fetus needs to
develop tolerance (Zaura et al. 2014). Furthermore, lactic
acid bacteria and enteric bacteria have been found in the
meconium, the first fecal discharge of neonates that was
thought to be sterile (Jimenez et al. 2008). These data
suggest that bacteria or at least bacterial DNA can come in
contact with fetal tissues and this does not automatically
lead to premature birth or spontaneous abortion. Thus,
during fetal life overt inflammatory responses towards
environmental or maternal (commensal) bacteria must be
prevented, to forestall premature birth or death of the fetus.
Underdeveloped or Repressed Immunity?
Stoppelenburg et al. (2014) have shown that umbilical cord
blood T cells fail to differentiate toward the pro-inflam-
matory Th17 lineage in the presence of autologous antigen-
presenting cells. In a separate study, they also showed that
neonatal T cells have an intrinsic mechanism that prevents
Th17 differentiation through the regulation of RORct ex-
pression, possible via DNA methylation and histone
acetylation (de Roock et al. 2013). This again indicates that
overt inflammatory responses are actively repressed in the
fetus and neonate. At the same time, this might pose a risk
to mother and child. Indeed, it has been shown that preg-
nant women have a 20-fold increased risk of developing
listeriosis; infection with Listeria bacteria that causes in-
fections of the central nervous system of the unborn, such
as meningitis (Southwick and Purich 1996). This is prob-
ably due to repressed Th1 cell proliferation and interferon
(IFN)-c production during pregnancy (Southwick and
Purich 1996).
To further prevent pro-inflammatory responses, the fetus
is surrounded by amniotic fluid. This amniotic fluid con-
tains anti-microbial peptides such as defensins and
lactoferrin. Furthermore, it contains endotoxin-neutralizing
histones and lipopolysaccharide (LPS)-binding protein that
might prevent Toll-like receptor (TLR) signaling and
possibly fatal immune responses for the unborn child
(Cherry et al. 1973; Espinoza et al. 2002; Kim et al. 2002).
Recently, it was shown in mice that epidermal growth
factor (EGF) in the amniotic fluid inhibits fetal TLR sig-
naling through binding to the EGF receptor on fetal
intestinal epithelial cells (Good et al. 2012). So, instead of
being underdeveloped and unresponsive, the fetus can re-
spond to antigens, however, these responses are actively
prevented.
Development of Mucosal Lymphoid Tissue During
Fetal Life
Meanwhile in the gut of the fetus, interspersed Peyer’s
patches develop around 11 weeks of gestation and func-
tional B and T cells can be found from 12 to 16 weeks,
respectively (Fig. 1) (Cupedo et al. 2005; Darrasse-Jeze
et al. 2005; Haynes et al. 1988; Hayward and Ezer 1974;
Michaelsson et al. 2006; Mold et al. 2008). Both the gut-
associated lymphoid tissue (GALT) and the intestinal
epithelium mature during the gestational period. Special-
ized epithelial cells called Paneth cells develop in the
colon and small intestine at 13.5 weeks of gestation. After
17 weeks, Paneth cells are confined to the small intestine
(Poulsen et al. 1996). Paneth cells reside at the bottom of
the crypts, secrete anti-microbial peptides and are
Table 1 continued
Factor Specific substance Immunological mechanism/clinical
effect on host
Model References
Vitamin D Increase CD8aa? intraepithelial T
cells
Human (Kang et al. 2012)
Treg induction by binding of VDR-
RXR to enhancer of Foxp3 gene
Mice (Bruce and Cantorna 2011)
Fermentation
products
SCFAs Recruitment of leukocytes and T cell
activation
Mice (Brown et al. 2003; Kim et al. 2013)
Starch Butyrate and acetate Treg differentiation via colonic DCs
and macrophages (via GPR109A
receptor)






(Han et al. 2007; Meijer et al. 2010; Park et al. 2004;
Quivy and Van Lint 2004)
Acetate or
propionate




(Tedelind et al. 2007)
Vegetables Glucosinolates (e.g.
TCDD)
Epigenetic modulation of Foxp3 and




(Bjeldanes et al. 1991; Singh et al. 2011)
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important in protecting the intestinal stem cells and
maintaining intestinal homeostasis (Bevins and Salzman
2011; Nieuwenhuis et al. 2009; Salzman et al. 2010). In
the human fetal intestine, goblet cells appear around
9–10 weeks of gestation (Kim and Ho 2010). Goblet cells
produce mucins that serve as a first line of defense against
luminal antigens. In addition to mucins (large glycopro-
teins), mucus consists of water, ions and immune
mediators such as immunoglobulin A (IgA) and anti-mi-
crobial peptides, which help clear pathogens (Hasnain
et al. 2013; Phalipon et al. 2002). Early during develop-
ment lymphoid precursor cells are present and spread to
Peyer’s patches and mesenteric lymph nodes (Husband
and Gleeson 1996). Memory T cells were found to be
relatively abundant in fetal spleen and in cord blood
samples from premature births. These cells comprised
about 25 and 10 % of the T cells, respectively, expressed
CD25 and were anergic (Byrne et al. 1994). At that time,
15–20 % of CD4? T cells in the fetus’ secondary lym-
phoid tissues are comprised of Tregs. Murine studies
suggest that these Tregs are largely induced by maternal
cells that cross the placenta and reside in fetal lymph
nodes (Mold et al. 2008). In this way, regulation of fetal
anti-maternal immunity is established. The authors also
suggest that this form of in utero-induced antigen-specific
tolerance might also be active in regulating immune re-
sponses after birth (Mold et al. 2008). Next to the GALT,
the nasopharynx-associated lymphoid tissue (NALT), and
bronchus-associated lymphoid tissue (BALT) are also part
of the mucosal-associated lymphoid tissue. The NALT
(named Waldeyer’s ring in humans), consists of the na-
sopharyngeal tonsil, tubal tonsils, palatine tonsils and
lingual tonsils (Perry and Whyte 1998). Its appearance is
similar to Peyer’s patches; follicles underneath follicle-
associated epithelium containing interspersed microfold
cells that can sample antigens (Breel et al. 1988a, b).
Tonsils are secondary lymphoid organs. The tonsillar
subepithelial space is formed by several lymphoid folli-
cles containing B and T cell areas. Tonsils are not
encapsulated like the spleen, but are lined by tonsillar
epithelium that invaginates forming crypts (Perry and
Whyte 1998). From the 14th week of gestation, B and T
cells populate the area under the tonsillar epithelium and
primary follicles develop from 16 weeks of gestation
(earlier than any other secondary lymphoid tissue). The
tonsils will keep growing until 7 years of age after which
they slowly involute (Passali 1992). While NALT is
present at birth, BALT develops from 3 to 4 days of age
(Breel et al. 1988a; Hameleers et al. 1989; Pabst and
Gehrke 1990). It is not until 3–4 weeks of age until B and
T cell areas are formed in the BALT (Breel et al. 1988a;
Pabst and Gehrke 1990).
Immune Modulation via Dietary or Bacterial Factors
During Fetal Life?
Recently, a specific subset of T cells with an invariant
receptor (mucosa-associated invariant T cells: MAIT) was
also found to be present in the second trimester of human
fetal tissues (Leeansyah et al. 2014). MAIT cells are in-
nate-like T cells that recognize antigens in complex with
the MHCIb-like protein MR1 (Treiner et al. 2003). MAIT
cells recognize microbial-derived riboflavin metabolites
and can subsequently produce IFN-c, tumor necrosis
factor (TNF) and interleukin (IL)-17 (Corbett et al. 2014;
Kjer-Nielsen et al. 2012; Le Bourhis et al. 2010). Inter-
estingly, these cells are present at high frequency in fetal
lung, liver and small intestine, and display a mature
phenotype (i.e., they express IL-18Ra? and CD8aa)
(Leeansyah et al. 2014). Compared to adult MAIT cells
Fig. 1 Development of
mucosal immunity before and
after birth. Contrary to what was
believed, the fetal immune
system contains mature T and B
cells that are actively repressed
by regulatory T cells. Of note,
the gut-associated lymphoid
tissue (GALT) and the nasal-
associated lymphoid tissue
(NALT) are present before
birth, while the bronchial-
associated lymphoid tissue
(BALT) develops after birth
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fetal small intestinal MAIT cells have an increased pro-
liferative capacity and can respond to bacterial stimulation
with production of IFN-c and IL-22 (Leeansyah et al.
2014). The factors that drive this fetal MAIT maturation
are currently unknown, but also might suggest that the
human fetal environment is not devoid of external or
environmental stimuli.
The fact that environmental factors can reach the fetal
immune system via the placenta, suggests that fetal im-
munity might be altered or enhanced by dietary or
microbial intervention in pregnant women. However, sci-
entific evidence on the effect of dietary intervention in
pregnant women on fetal immunity is limited. Rautava
et al. (2012) report that women that received either Bifi-
dobacterium lactis or Bifidobacterium lactis together with
Lactobacillus rhamnosus GG 14 weeks prior to elective
cesarean section showed altered TLR expression in the
exfoliated cells present in the meconium of the newborn as
compared to the placebo group. However, others have
shown that dietary supplementation with probiotics during
late pregnancy might alter maternal immune parameters,
but does not alter fetal immune responses (Boyle et al.
2008; Vitali et al. 2012). Additionally, while supplemen-
tation with galacto-oligosaccharides and long-chain fructo-
oligosaccharides alters maternal fecal microbiota (increase
of bifidobacteria), it did not affect fetal immunity as
measured by cord blood cell stimulation assays (Shadid
et al. 2007). However, experiments performed with preg-
nant mice suggest that live bacteria can transfer from the
mother to the fetus. Labeled Enterococcus faecium that
were orally given to pregnant mice could be cultured from
the amniotic fluid as well as from the mammary glands of
the mothers (Jimenez et al. 2005). Interestingly, in mice
treated with a diet devoid of vegetable material, decreased
numbers of intraepithelial lymphocytes are seen as well as
a reduction in type three innate lymphoid cells (RORct?
ILC) in the intestines (Kiss et al. 2011; Lee et al. 2012; Li
et al. 2011). Additionally, in a recent paper, van de Pavert
et al. (2014) have shown in mice that maternal diet derived
vitamin A induces lymph nodes in the unborn pups. Pups
derived from mice fed vitamin A-deficient diets had
markedly reduced lymph node size and decreased effi-
ciency of immune responses. In this paper, van der Pavert
showed that retinoic acid (the metabolite of vitamin A) is
necessary for differentiation of lymphotoxin inducer cells
that play a crucial role in lymph node formation (van de
Pavert et al. 2014).
In conclusion, while increasing evidence suggests a di-
rect interaction between the maternally derived
environmental factors (such as diet and microbes) and the
fetus, more research is warranted to investigate the
mechanisms by which these factors might (beneficially)
alter fetal and subsequent neonatal immunity.
Neonatal Life
Cesarean Section Versus Vaginal Birth: Effect
on the Microbial Composition
During birth, the amniotic membranes rupture and the
unborn child will passage through the birth canal. This
birth canal is not sterile and during labor the child will get
exposed to vaginal bacteria, maternal skin and feces fol-
lowed by exposure to environmental antigens (Fanaro et al.
2003). This exposure has a profound impact on the host.
Here, we summarize what is known in this interesting re-
search field (see also Table 2).
Studies comparing children born vaginally or by ce-
sarean section have shown differences in microbial
community and immune responses. For example, a
Venezuelan cohort showed that most vaginally delivered
infants acquired a bacterial composition dominated by
Lactobacillus, Prevotella, or Sneathia; species that are
found in their mothers vaginal microbiota (Dominguez-
Bello et al. 2010). In contrast, infants born by cesarean
section displayed a bacterial community dominated by
Staphylococcus, Corynebacterium, and Propionibacterium,
typical skin bacteria (Dominguez-Bello et al. 2010).
A Finnish study compared the microbiota and antibody
production at 1 month after birth and showed that children
delivered by cesarean section harbored fewer Bifidobacte-
ria and were shown to mount a stronger humoral immune
response (Huurre et al. 2008). The authors reported that
during the first year of life, infants born vaginally displayed
lower total IgA-, IgG- and IgM-secreting B cells in pe-
ripheral blood. The mode of delivery also has been
reported to affect serum cytokine levels. Malamitsi-Puch-
ner et al. (2005) reported that soluble IL-2 receptor, IL-1b
and TNF-a were significantly higher in cases of vaginal
delivery than in cases of elective cesarean section in neo-
nates at day 1 (IL-1b, IL-2 Receptor and TNF-a) and day 4
(IL-2R, TNF-a) of life. These two studies might suggest
that children born vaginally have lower humoral and higher
cellular immunity in early life, compared to children born
by cesarean section. However, more data will be necessary
to support this hypothesis. Several studies report increased
abundance of Bifidobacteria and Bacteroides in vaginal-
delivered children compared to children born by cesarean
section (Biasucci et al. 2010; Huurre et al. 2008). Addi-
tionally, analysis of bacterial colonization from birth to
12 months of age in a cohort of Swedish, Italian and British
infants using culturing techniques showed that children
delivered by cesarean section displayed more Klebsiella,
Enterobacter, and Clostridia, including the pathobiont
Clostridium difficile compared to vaginally delivered ba-
bies (Adlerberth et al. 2006, 2007; Penders et al. 2006).
Interestingly, studies performed in Western countries
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revealed that children born by cesarean section take
6 months to a year to acquire the same levels of Bac-
teroides, Bifidobacteria and Escherichia coli colonization
as vaginally born children display directly after birth
(Adlerberth et al. 2006; Hall et al. 1990; Penders et al.
2006). In contrast, children born by cesarean section in the
developing world catch up much quicker indicating that the
environment is an important factor in colonization patterns
after birth (Adlerberth et al. 1991).
Cesarean Section Versus Vaginal Birth: Effect
on Allergic Diseases
Thus, from these studies it seems that vaginally born
children harbor bacterial species that have been considered
beneficial (Bifidobacteria), while children born by cesarean
section are more prone to harbor species that are associated
with, but do not necessarily lead to, disease (E. coli and
Clostridia). Indeed, colonization with Clostridium difficile
has been associated with a higher risk of a diagnosis of
atopic dermatitis (Penders et al. 2007, 2013). Several meta-
analyses have shown that babies born by cesarean section
are at higher risk to develop allergy, including food aller-
gies. Interestingly, in a Norwegian birth cohort, it was
shown that children of allergic mothers who were born by
cesarean section had a sevenfold increased risk of devel-
oping food allergy to egg, fish or nuts (Eggesbo et al.
2003). This effect was not seen in children whose mothers
were not allergic indicating that a predisposition exists that
together with birth by cesarean section can lead to food
allergy. Likewise, in a German cohort, babies with a family
history of allergy and born by cesarean section also showed
an increased risk of allergic sensitization to food allergens
compared with babies at risk born vaginally (Laubereau
Table 2 Effect of microbial colonization on host immunity






Stronger humoral response (higher levels of IgA,
IgG- and IgM-secreting B cells)
Human (Biasucci et al. 2010; Huurre et al. 2008)






Higher risk of allergies (excl. inhalant atopy and
eczema)
Human (Adlerberth et al. 2006, 2007; Bager et al.






Might predispose to development of autoimmunity,
and childhood infections, atopy and asthma










Associated with protection from autoimmune
disease, and childhood infections, atopy and
asthma












Increased Foxp3 expression in colitis model Mice (Strauch et al. 2005)
Autologous bacteria Tolerance induction that protects against IBD Mice (Duchmann et al. 1995)
Altered Schaedler flora Treg induction Mice (Hapfelmeier et al. 2010; Macpherson et al.
2005; Macpherson and Uhr 2004)
Bacteriodes fragilis Treg induction in a polysaccharide A-TLR2
dependent manner
Mice (Round and Mazmanian 2010)
Faecalibacterium
prautznitzii
Enhances anti-inflammatory responses Mice (Qiu et al. 2013; Sokol et al. 2008)
Cluster IV, XIVa and
XVIII of Clostridia
Induce Treg frequency and inducible T-cell co-
stimulator
Mice (Atarashi et al. 2013)
Segmented filamentous
bacteria
More Th17 cells in small intestinal lamina propria,
less in colon
Mice (Gaboriau-Routhiau et al. 2009; Ivanov
et al. 2009)
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et al. 2004). Finally, a large meta-analysis in which 26
studies on the effect of delivery by cesarean section on one
or more allergies were described showed that cesarean
section was associated food allergy, atopy, allergic rhinitis,
asthma, and hospitalization for asthma. However, they
found no association with inhalant atopy and eczema/ato-
pic dermatitis (Bager et al. 2008). Since children born by
cesarean section have an altered bacterial community, it is
generally thought that this altered microbiota can lead to
differences in mucosal immune tolerance which can pre-
dispose to the development of allergies (Maynard et al.
2012). Indeed in Dutch cohort, colonization by Clostridium
difficile (associated with cesarean section) at an age of
1 month was associated with wheeze and eczema in the
first 6 years of life and with asthma from age 6 (van
Nimwegen et al. 2011). Although the associations exist,
reports on the mechanisms how these changes early in life
lead to disease are understandingly scarce. However, from
animal studies, we do know that exposure to certain bac-
terial species has an important impact on host immunity. In
the next section, we will discuss the current knowledge of
microbial modulation of host immunity generated using
animal models.
How do Colonizing Microbes Influence Host
Immunity?
In the last decades, it has become clear that the composi-
tion of the microbial community has profound influence on
our health. Most of this knowledge derives from studies
using gnotobiotic experimental animals. These studies
show that colonization by different microbial species early
in life has clear effects on the development of the intestinal
mucosal immune system. Interestingly, host responses to
microbial colonization are highly conserved between spe-
cies. A study investigating zebrafish responses towards
colonization revealed 59 responses that are conserved be-
tween mouse and zebrafish. These responses included
pathways involved in epithelial proliferation, promotion of
nutrient metabolism, and innate immune responses (Rawls
et al. 2004). Several immune cells and mediators are in-
fluenced by the microbiota, for example, germ-free mice
that are devoid of bacteria have almost no IgA-secreting
plasma cells. Only upon colonization with specific sub-
types of bacteria, IgA plasma cells are restored to levels
seen in conventionally raised mice (Cebra 1999; Crabbe
et al. 1968). IgA is the predominant antibody secreted by
plasma cells in the mucosal tissues (Pabst et al. 2008).
Low-affinity, poly-specific IgA is believed to prevent ad-
hesion of commensal bacteria to epithelial cells, while
high-affinity, mono-specific IgA neutralizes toxins and
pathogens (Hapfelmeier et al. 2010; Macpherson et al.
2005; Macpherson and Uhr 2004).
Studies have also shown that germ-free animals have
altered Treg frequency. In a transfer model of colitis, it
was shown that co-transfer of CD4?CD62L- cells into
SCID mice prevented colitis induced by CD4?CD62L?
cells only when those cells were derived from conven-
tionally raised mice. The CD4?CD62L- cells from germ-
free animals were not able to suppress the colitis. This
associated with a low expression of regulatory T cell
marker Foxp3 in this population form germ-free mice
(Strauch et al. 2005). Already in 1995, Duchmann et al.
(1995) reported that hypo-responsiveness exists towards
the hosts’ autologous bacteria. Lamina propria mononu-
clear cells and peripheral blood mononuclear cells
(PBMCs) did respond towards heterologous intestinal
microbes. In patients with inflammatory bowel disease
this tolerance towards autologous bacteria was lost
(Duchmann et al. 1995). Together these studies clearly
indicated that Tregs are directly or indirectly induced by
the intestinal microbiota.
Using the altered Schaedler flora (ASF), a mixture of
eight bacterial species including Lactobacilli, Bacteroides,
Eubacterium, Mucispirillum, Fusiform and Clostridial
species, Macpherson and colleagues demonstrated that
ASF colonization of germ-free mice increased the in-
ducible Treg frequency in the colonic lamina propria by
twofold (Hapfelmeier et al. 2010; Macpherson et al. 2005;
Macpherson and Uhr 2004). Likewise, it was shown that
Bacteroides fragilis was able to induce Tregs upon
colonization. Interestingly, when germ-free mice were
given B. fragilis devoid of polysaccharide A (B. fragilis
DPSA), Tregs were not induced (Round and Mazmanian
2010). Further experiments showed that polysaccharide A
induction of Foxp3 on CD4? T cells required TLR2 ac-
tivation (Round and Mazmanian 2010). Likewise,
Faecalibacterium prautznitzii has also been demonstrated
to enhance anti-inflammatory responses (Qiu et al. 2013;
Sokol et al. 2008). This indicates that bacteria and their
cell wall components are important mediators of immune
cell differentiation. Recently, Atarashi et al. (2013)
inoculated mice with a healthy human fecal sample, and
selected for mice enriched in Treg-inducing species. From
these selected mice, they isolated 17 strains of bacteria
that were able to enhance Treg frequency and induce IL-
10 and inducible T cell co-stimulator (ICOS) upon
inoculation into germ-free mice. Identification of these 17
strains revealed that these bacteria were members of the
clusters IV, XIVa and XVIII of Clostridia, which lack
prominent toxins and virulence factors (Atarashi et al.
2013).
More evidence for the bacterial specific effects on
immune development was reported by Ivanov et al.
(2009) who have shown that the ability to increase the
number of Th17 cells in the small intestinal lamina
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propria associated with the presence of segmented
filamentous bacteria in mice (Gaboriau-Routhiau et al.
2009). Th17 cells are T cells that produce IL-17A, IL-
17F and IL-22 and have been shown to play a role in
inflammatory responses and host defense against bacte-
rial and fungal pathogens (Bettelli et al. 2007;
McKenzie et al. 2006; Ouyang et al. 2008). Conversely,
in the colon lamina propria, it was shown that germ-free
mice harbor more Th17 cells than conventionally raised
mice. Upon microbial colonization epithelial cells pro-
duce IL-25, which in turn inhibits (either directly or
indirectly) the expression of IL-23 by antigen-presenting
cells (Zaph et al. 2008). IL-23 is a cytokine that is
described to be necessary for Th17 pool maintenance
(Zhou and Littman 2009). Reduction of IL-23, therefore,
results in decreased numbers of Th17 cells in the colon.
Likewise, Corbett et al. (2014) reported that bacteria
with an active vitamin B2 (riboflavin) pathway generate
epitopes that (in conjunction with host metabolites) can
be recognized by the MAIT cells via MR1. This finding
again illustrates that colonization by (specific subsets of)
bacteria can give rise to different mucosal immune
environments.
Recently, much attention has been directed towards a
newly discovered cell subset: innate lymphoid cells
(ILCs). Three types of ILCs have been identified: T-bet?
ILCs (including NK cells, ILC1), GATA3? ILCs (ILC2)
and RORct? ILCs (ILC3) (Sonnenberg and Artis 2012).
These ILCs are in close contact with the microbes since
they reside in between the epithelial cells (Maloy and
Powrie 2011; Sonnenberg et al. 2011; Spits and Cupedo
2012; Spits and Di Santo 2011; Veldhoen and Withers
2010). While Gata3? and T-bet? ILC development does
not seem to depend on microbial colonization, this is not
completely clear for the RORct? ILCs. Some studies
show normal development, while other show reduced
frequency of RORct ILCs in germ-free mice (Reynders
et al. 2011; Sanos et al. 2009; Satoh-Takayama et al.
2011; Sonnenberg and Artis 2012; Sonnenberg et al.
2011; Vonarbourg et al. 2010). RORct ILCs express
TLR2 and can therefore directly be activated by bacterial
ligands (Crellin et al. 2010).
In conclusion, colonization is an important process
during which the immune system develops to a certain set-
point in each individual. Therefore, colonization by Bifi-
dobacteria or Bacteroides species (vaginally delivered
children), might result in a different immune cell-repertoire
(for example, T cell subsets) and distribution than
colonization by E. coli (Cesarean section), thereby leading
to a different immunological set-point that may or may not
predispose (in combination with host genetic suscepti-
bility) towards certain diseases.
Dietary Exposure and Host Immunity in Early Life
Bottle Feeding Versus Breastfeeding
Next to bacteria, the newborn encounters several new en-
vironmental antigens of which most will be derived from
the diet. Therefore, children that will be breastfed will be
exposed to different dietary antigens than those that will be
bottle-fed. Human breast milk contains immunoglobulins,
cytokines, growth factors, lysozyme, lactoferrin and a
complex mix of milk oligosaccharides (Chatterton et al.
2013; Kosaka et al. 2010; Wagner et al. 2008). Breast milk
and colostrum contain large amounts of IgA, but also im-
mune cells and cytokines, and soluble TLR2 that might
help restrict innate immune activation by microbes
(LeBouder et al. 2003; Verhasselt 2010). In addition, breast
milk contains growth factors that fortify the neonates’ ep-
ithelial barrier (Wagner et al. 2008). Lactoferrin in the
breast milk can bind free iron, needed for bacterial growth,
thereby reducing bacterial load. In addition, lactoferrin can
prevent pathogenic bacteria (such as ETEC) from adhering
to the epithelial cell layer through binding of E. coli
colonization factors (de Oliveira et al. 2001; Giugliano
et al. 1995). However, in the continuing battle between
host and pathogens, several pathogenic species developed
mechanisms to counteract the action of lactoferrin either by
using receptors that can acquire iron from lactoferrin
(Neisseria) or secrete proteins that specifically bind lacto-
ferrin thereby preventing its function (Streptococcus
pneumoniae) (Hammerschmidt et al. 1999; Ling and
Schryvers 2006; Senkovich et al. 2007).
The structure of breast milk oligosaccharides has been
shown to be very diverse and depend on several factors
including diet, lifestyle, and ethnicity (Thurl et al. 2010).
Oligosaccharides can improve diversity and rate of meta-
bolism of the microbiota (Oozeer et al. 2013; Scholz-
Ahrens et al. 2007; Scholz-Ahrens and Schrezenmeir
2007). Also, breastfeeding has an impact on the composi-
tion of the microbiota. Breastfeeding is associated with
high numbers of Bifidobacteria in the gastrointestinal tract
of the newborns, whereas bottle feeding resulted in more
intestinal Bacteroides and Clostridia (Coppa et al. 2004;
Fallani et al. 2010; Vos et al. 2007). Recently, it was shown
that Lactobacilli could be cultured from saliva in 27.8 % of
exclusively and partially breast-fed infants, but not from
formula-fed infants (Holgerson et al. 2013; Vestman et al.
2013), indicating that the oral microbiome is also influ-
enced by infant feeding (Zaura et al. 2014). Furthermore, it
has been shown that human milk glycans can protect in-
fants from enteric pathogens (Newburg 2005, 2012).
Insulin-like growth factor is important for wound healing
and tissue repair and EGF plays a role in cell proliferation
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and differentiation, induces mucus production by intestinal
Goblet cells and can suppress pro-inflammatory cytokines
(Clark et al. 2006; Halpern et al. 2003). Interestingly, hu-
man milk also contains bacteria. Culture-dependent
mechanisms have shown the presence of Staphylococcus,
Streptococcus and Bifidobacterium species (Heikkila and
Saris 2003; Martin et al. 2009). Subsequently, sequence
analysis has identified the presence of DNA from nine
different bacterial genera (Hunt et al. 2011). Interestingly,
recently it was reported that house dust mite allergen,
DerP1, is present in human breast milk. Subsequent testing
of breast milk containing DerP1 in a mouse model revealed
that instead of protecting these mice from allergic re-
sponses, they were sensitized (Macchiaverni et al. 2014).
This suggests that not only neonates are exposed to dietary
antigens early in life via breast milk, they are also exposed
to respiratory allergens via breast milk, and this does not
always lead to tolerance to the antigens but may well result
in sensitization.
Maternal IgA is reflective of the environment of mother
and child and therefore can protect the newborn against
possible pathogens that he or she might encounter right
after birth. Maturation of the IgA-producing plasma cells
slowly develops after birth. While, IgA H chain transcripts
are found in cord blood as early as 27 weeks of gestation,
at 60 weeks of age, somatic mutation frequency of IgA H
chain transcripts only reaches 25 % of the adult values,
with little evidence of Ag-driven selection (Rogosch et al.
2012). Therefore, maternal IgA from the milk will equip
the newborn with antigen-specific humoral immunity at the
time the child itself does not have a fully developed
repertoire. Interestingly, recently it was shown in mice that
breast milk-derived IgA modulates the composition of the
microbial community in the gastrointestinal tract (Rogier
et al. 2014). Next to preventing bacterial infections, ma-
ternal IgA can also reduce the oxidative burst and represses
TNF-a and IL-6 production by human monocytes (Wolf
et al. 1994, 1996).
Protection from Disease?
There is a long debate in the literature about the possible
beneficial effect of (prolonged and/or exclusive) breast-
feeding for children at risk for type 1 diabetes. Already in
1984, Borch-Johnson et al. (1984) reported an inverse
correlation between breastfeeding and incidence rates of
childhood type 1 diabetes. Several other studies confirmed
this correlation (Mayer et al. 1988; Rosenbauer et al.
2008), while others did not (Couper et al. 1999; Hummel
et al. 2000). Animal studies using the spontaneous diabetic
rat model (the BB-DP rat) showed that prolonged exclusive
breastfeeding decreased diabetes incidence by 40–50 %
and associated with increased frequency of Treg cells and
less pro-inflammatory cytokine secretion in the mesenteric
lymph nodes (Brugman et al. 2009b). Furthermore, an-
tibiotic treatment reduces the incidence in both the BB-DP
rat and the NOD mouse model for spontaneous diabetes
(Brugman et al. 2006; Schwartz et al. 2007). Interestingly,
in the BB-DP rat, the composition of the microbiota before
onset of disease differed between BB-DP rats that did and
rats that did not develop diabetes, suggesting that microbial
dysbiosis occurs prior to disease onset (Brugman et al.
2006). Likewise, several studies report an association be-
tween breast milk and protection against infection such as
diarrhea, atopic diseases and asthma during childhood
(Gdalevich et al. 2001a, b; Sachdev et al. 1991; van Odijk
et al. 2003). Interestingly, a meta-analysis of 12 human
studies showed that the protective effect in most studies
correlated with the (high) concentrations of transforming
growth factor (TGF)-b1 or TGF-b2 in the milk (Oddy and
Rosales 2010). A recent meta-analysis of studies published
between 1983 and 2012 on breastfeeding and asthma in
children reported a strong protective association at ages
0–2 years between breastfeeding and asthma, which di-
minished over time (Dogaru et al. 2014a, b). The
availability of nutrients, and especially of milk oligosac-
charides, in the intestinal tract of newborns also has a
profound influence on the microbial species that are able to
survive there. Indeed, it has been shown that breastfeeding
and bottle feeding result in different microbial colonization
patterns, which results in different host immune responses
(Schwartz et al. 2012).
To improve the composition of infant formulas for
mothers that cannot provide breastfeeding to their child,
investigators try to develop formulas that resemble the
composition of human breast milk. Recent developments
include the use of prebiotics to provide non-digestible
oligosaccharides and probiotics. Like breast milk, bovine
milk also contains several proteins that have an im-
munomodulatory function such as large quantities of
immunoglobulins, lactoferrin, caseins and cytokines like
TGF-b, but only very low levels of oligosaccharides (van
Neerven et al. 2012). Many of these proteins are, surpris-
ingly, active across the species barrier. The active form of
bovine TGF-b2 (the predominant cytokine in milk) is even
100 % identical to human TGF-b2, and bovine IL-10 is
fully comparable to human IL-10 in its anti-inflammatory
effects of human monocytes and dendritic cells (Chatterton
et al. 2013; den Hartog et al. 2011). Bovine IgG can bind to
human Fc gamma receptors on monocytes and neutrophils
(den Hartog et al. 2014; Kramski et al. 2012), and bovine
IgG recognizes a wide range of pathogens that can also
infect humans such as respiratory syncytial virus (den
Hartog et al. 2014; Xu et al. 2006). Bovine colostrum, that
is extremely rich in bovine IgG, has been shown to sig-
nificantly reduce recurrent diarrhea in AIDS patients,
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showing that bovine IgG can have an anti-pathogenic effect
in humans (Floren et al. 2006). Milk also contains anti-
microbial proteins, most prominently lactoferrin, lac-
toperoxidase and lysozyme. Lactoferrin was shown to
protect low birth weight infants against necrotizing ente-
rocolitis (Manzoni et al. 2014). In line with this, it has
already been known for a long time that growing up in a
farm environment lowers the risk of developing allergies
(von Mutius 2012). Next to exposure to farm animals,
drinking farm milk has also been implicated as a factor that
might reduce allergy risk (Loss et al. 2012; van Neerven
et al. 2012; van Neerven 2014). A recent study showed that
consumption of raw milk inversely associated with devel-
opment of rhinitis, respiratory tract infections, otitis, and
fever in infants (Loss et al. 2015). However, since bovine
milk is heated and homogenized, a substantial proportion
of these protective proteins will be denatured in milk
products (van Neerven 2014). New insights into how di-
etary components influence host immunity, continuously
promote the development of health-stimulating or disease-
preventing (infant) nutrition.
Fermentation Products: How Bacterial Products
Influence Host Immunity
The microbes that are present in the intestinal tract of
mammals are important for digestion of foods that would
otherwise not be available to the host. The products of
bacterial fermentation, such as butyrate, are readily taken
up by colonocytes for energy, but also have important
immunological effects. Most of the bacteria that reside in
the mammalian gastrointestinal tract are saccharolytic,
meaning that they mainly feed on carbohydrates (Cum-
mings and Macfarlane 1991). Human milk
oligosaccharides are complex glycan molecules that are
present in very high concentrations in breast milk. Several
studies have shown that milk oligosaccharides influence
the composition of the intestinal microbiota (Bode 2009;
Gauhe et al. 1954; LoCascio et al. 2007). Human milk
oligosaccharides promote the growth of Bifidobacteria
(Gauhe et al. 1954; LoCascio et al. 2007), and prevent
pathogenic bacterial adherence to epithelial cells by acting
as a soluble ligand for glycan receptors (Hong et al. 2009;
Lomax and Calder 2009; Naarding et al. 2005; van Liempt
et al. 2006). Next to effects on the microbiota milk
oligosaccharides and non-digestible carbohydrates have
also been show to directly influence host immunity and
epithelial cell biology (reviewed in Vos et al. 2007).
Short chain fatty acids (SCFAs) are the end products
generated by the colonic microbiota (Macfarlane and
Macfarlane 2003). The type of SCFA formed is dependent
on the substrate provided. Acetate and butyrate are mainly
the result of starch fermentation, while acetate is the end
product from the fermentation of pectin and xylan (Englyst
et al. 1987). The succinate and acrylate pathways have
been shown to lead to propionate production (Flint et al.
2012; Macy and Probst 1979; Seeliger et al. 2002;
Watanabe et al. 2012), and some bacteria can produce
propionate from deoxy sugars such as fucose and rhamnose
or lactate (Saxena et al. 2010). SCFAs can interact with G
protein coupled receptors (GPR43, GPR41 and GPR109a)
(Brown et al. 2003). GPR43 is mainly located on neu-
trophils, and at lower levels on PBMCs and monocytes,
while GPR41 is expressed on PBMCs but not on neu-
trophils, monocytes and dendritic cells. Both receptors
have also been found on intestinal epithelial cells, and re-
cently it has been shown that binding of SCFAs to these G
protein coupled receptors can promote inflammatory re-
sponses in mice. Binding of SCFAs to GPR43 and GPR41
induced colon epithelial cell production of chemokines,
recruited leukocytes and activated effector T cells (Kim
et al. 2013). Niacin receptor GPR109A has recently been
shown to also be a receptor for butyrate in the colon. Singh
et al. (Singh et al. 2014) reported that Gpr109a signaling
induced differentiation of Tregs and IL-10 producing T
cells through effects on colonic macrophages and dendritic
cells. Both propionate and acetate can reduce LPS-induced
TNF-a release from human neutrophils (Tedelind et al.
2007), and butyrate seems to inhibit chemotactic effects on
human monocytes (Meijer et al. 2010). Furthermore,
SCFAs have been shown to reduce cell adhesion thereby
preventing immune cell infiltration (Miller et al. 2005);
(Zapolska-Downar and Naruszewicz 2009). Interestingly,
butyrate can inhibit histone deacetylase (HDAC). HDACs
prevent gene transcription by keeping the chromatin in a
closed form, so transcription is prevented. Butyrate inhibits
this effect leading to hyper-acetylation and open chromatin
(Davie 2003). Butyrate has been reported to have anti-
inflammatory effect through its HDAC activity on the NF-
jB pathway, IL-5 expression and COX-2 expression (Han
et al. 2007; Park et al. 2004; Quivy and Van Lint 2004).
Another interesting example of the effect of butyrate on
host immunity comes from the study by Atarashi et al.
(2013). They isolated 17 strains Clostridial species that
were able to enhance Treg frequency and induce ICOS
upon inoculation into germ-free mice (Atarashi et al.
2013). In a follow-up study of the same research group,
they showed that these Clostridiales (indirectly or directly)
induced butyrate that subsequently induced functional
colonic Treg cells, via epigenetic modification of the
Foxp3 gene in T cells (Furusawa et al. 2013).
In conclusion, SCFAs are able to modify host immunity
directly by binding to receptors on host cells or indirectly
through epigenetic changes of host DNA. These modifi-
cations result in activation or repression of host immune
genes and the outcome will depend on the type of SCFA
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and host (immune) cell type studied. Whether SCFAs can
induce epigenetic changes in the host throughout life or
whether a specific window (early in life) exists is currently
unknown.
Vitamin A and D
Vitamin D deficiency together with vitamin A deficiency
are two of the most common food-related medical condi-
tions worldwide. As vitamin A and D are conveyed to the
newborn via breast milk, vitamin A and D status of the
mother is very important for the developing child. Vitamin
D deficiency leads to poor skeletal development and bone
and joint deterioration, while vitamin A deficiency is one
of the important causes of blindness in children (Khan et al.
2007; Wong et al. 2014). Appropriate vitamin D status has
been reported to convey protection against several cancers,
bacterial infections and autoimmune diseases such as
rheumatoid arthritis and multiple sclerosis (Glade 2013).
Also, low vitamin D levels during pregnancy associates
with increased risk for type 1 diabetes in the offspring.
However, too much vitamin D (especially D2) might lead
to local tissue intoxication (reviewed in Glade 2013). In
recent years, vitamin A and D have received a lot of at-
tention from immunologists. Vitamin A can be converted
into retinal and subsequently into retinoic acid by dendritic
cells and epithelial cells. In an elegant paper, Coombes
et al. (2007) showed that in mice, retinoic acid together
with TGF-b are essential for promotion of Tregs by
CD103? DCs. Recently, it was also shown that retinoic
acid can promote the development of human CD103?
dendritic cells from monocytes (den Hartog et al. 2013).
The CD103? intestinal DC subset can convert retinal into
retinoic acid because it expresses the retinal dehydrogenase
enzymes (RALDH1 and RALDH2) (Coombes et al. 2007).
Retinoic acid has been shown to inhibit Th17 and the
conversion of Tregs into T follicular helper cells, and in-
duce intestinal mucosal homing molecules CCR9 and a4b7
(Benson et al. 2007; Iwata et al. 2004; Mora et al. 2003;
Mucida et al. 2007; Sun et al. 2007; Takahashi et al. 2012).
Also, retinoic acid is important for IgA-secreting cells,
since mice deficient for vitamin A lack these cells in the
small intestine (Mora et al. 2006). There have been reports
that miR-10a, a microRNA induced by retinoic acid in
Th17 cells can induce expression of T-bet (associated with
Th1 cells) (Takahashi et al. 2012). This indicates that next
to Tregs, retinoic acid might also induce Th1 cells. Indeed,
in an inflammatory environment retinoic acid could induce
Th1 immunity (DePaolo et al. 2011). Vitamin A uptake via
the diet, does not only influence the immune system of the
mother, but also influences the fetal immune system. As
shown by van de Pavert et al. (2014), pups derived from
mice fed vitamin A-deficient diets had markedly reduced
lymph node size and decreased efficiency of immune
responses.
Vitamin D has been reported to enhance regulatory T
cell induction via binding of the VDR-RXR (vitamin D
receptor-retinoic X receptor) binding to an enhancer in the
Foxp3 gene (Kang et al. 2012). While vitamin D deficiency
causes a reduction in CD8aa? intraepithelial T cells
(Bruce and Cantorna 2011). Recently, Spencer et al. (2014)
showed that vitamin A deficiency leads to severely di-
minished type 3 innate lymphoid cells (ILC3s), which
results in compromised immunity to acute bacterial infec-
tion. Additionally, vitamin A deprivation resulted in
increased IL-13-producing ILC2s and resistance to nema-
tode infection in mice (Spencer et al. 2014). Since vitamins
A and D can have several direct and indirect effects on
cells and signaling pathways, further research is necessary
to understand their complete role in immune modulation.
These findings, however, suggest that exposure to certain
dietary factors (both in mother and child) can have pro-
found influence on the development and effectiveness of
the immune response. As with many multi-factorial dis-
eases, the interplay between host, microbes and dietary
exposure might be different in each individual patient,
making it extremely difficult to find causal relations rather
than incidental associations. This is very well illustrated by
what is known for inflammatory bowel disease (IBD).
When Homeostasis between Host and Microbes is Lost:
the Case of IBD
In recent years, genome-wide association studies have re-
vealed many single nucleotide polymorphisms (SNPs) in
host genes that are associated with multi-factorial diseases.
For example, in IBD[160 genes are found to be associated
with either ulcerative colitis and Crohn’s disease or both
(Ventham et al. 2013). Each and every patient, therefore,
can have a unique combinations of these SNPs. Interest-
ingly, several of these associated genes has a role in
bacterial–host interaction. Studies performed using ex-
perimental animals showed that knock-outs of these genes
(such as Nod2 or enteric defensins) can change the in-
testinal microbial community (Salzman et al. 2010; Secher
et al. 2013). Subsequently, changes in microbial commu-
nity can influence disease susceptibility. The IL-10 knock-
out mice, for example, does not develop colitis under germ-
free conditions. Interestingly, narrow and broad spectrum
antibiotics can prevent disease in IL-10-/- mice under
specific pathogen-free conditions (Hoentjen et al. 2003).
Furthermore, we have shown that that the composition of
zebrafish intestinal microbiota can determine recruitment
of different immune cells, enterocolitis susceptibility and
severity (Brugman et al. 2009a).
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An illustration of influence of gene alterations on mi-
crobial dysbiosis and disease susceptibility comes from the
studies performed by Garrett et al. (2007). Mice deficient
for transcription factor T-bet and Rag2 (TRUC mice)
showed increased TNF-a production by colonic dendritic
cells leading to increased apoptosis of colonic epithelial
cells and spontaneous colitis. This colitis was dependent on
the intestinal microbiota since treatment of TRUC mice
with a combination of antibiotics cured the mice from
colitis. Later studies confirmed that TRUC mice have an
altered microbiota (presence of Klebsiella pneumoniae and
Proteus mirabilis) (Garrett et al. 2010). This colitis was
also transmissible via the microbiota, since co-housing
adult TRUC mice and wild-type (WT) mice (3:1) rendered
WT mice more susceptible to develop colitis. Likewise,
when a TRUC mother fostered pups of Rag2-/- or WT
mice, these mice pups were also more susceptible and
developed colitis that was histologically similar to colitis in
TRUC mice (Garrett et al. 2010).
Another study that illustrates the importance of a func-
tioning adaptive immune system was performed using
zebrafish. In zebrafish, lymphocytes deficiency leads to
failure to suppress bacteria of the order Vibrionales (that
contains known fish pathogens) (our own unpublished ob-
servations). Adoptive transfer of T lymphocytes could
actively suppress outgrowth of these Vibrionales. Addi-
tionally, zebrafish T lymphocytes are able to induce
epithelial Cxcl8-l1 expression, thereby augmenting mu-
cosal immune responses (Brugman et al. 2014). In
summary, these studies emphasize that genetic deficiencies
(of genes involved in mucosal immunity) can modify the
mucosal environment and allow for modulation of the
microbiota which in turn can alter susceptibility towards
disease. This clearly illustrates that modulation of the gut
microbiota might be beneficial for IBD patients. Indeed,
Sokol et al. (2008, 2009) identified Faecalibacterium
prausnitzii as an anti-inflammatory commensal bacterium,
which was severely reduced in Crohn disease patients.
These studies have encouraged fecal transplantation as a
therapy for IBD patients, which results in remission in
some but not all patients (Angelberger et al. 2013; Kao
et al. 2014; Rubin 2013). Clearly, future research to elu-
cidate the complex interaction between host, diet and
microbes in the context of chronic intestinal inflammation
and during health is dearly needed.
Timing of Exposure, Does a Window of Opportunity
Exist?
Next to investigating the different pathways by which food
and microbes alter host immunity, investigation on the
concept of timing will be crucial. It has been suggested,
that a window exists early in life when microbes alter host
immunity, after which a set point is reached and home-
ostasis is established. There is indication that some
processes might indeed take place in a specific time win-
dow, where after they cannot be changed again. For
example, invariant natural killer T cells (iNKT) cells, a
subset of invariant T cells that recognize glycolipids in the
context of MHC-like molecule CD1d, were found to be
more abundant in the colon (and lungs) of germ-free mice
(Olszak et al. 2012). These germ-free mice displayed in-
creased morbidity in models of IBD and allergic asthma.
The increased number of iNKT cells in the colon (and
lungs) of germ-free mice was shown to be the result of high
expression of the chemokine CXCL16. Colonization of
neonatal—but not adult—germ-free mice protected the
animals from this mucosal iNKT accumulation and related
pathology (Olszak et al. 2012). This difference in iNKT
accumulation associated with epigenetic modifications that
enabled modification of CXCL16 expression early in life,
but not at adult age. This suggests that a host develop-
mental (epigenetic) program exists that allows for
environmental agents to shape immune responses only at
certain time points of life. However, other studies suggest
microbial and dietary modulation can also affect host im-
munity in later life. The success of fecal transplants in
obese people and inflammatory bowel disease patients
suggests that lifelong modification of diet and microbes
might be beneficial (Smits et al. 2013). Likewise, it has
been shown that glucosinolates derived from vegetables in
the diet, such as cabbage and broccoli, can activate the aryl
hydrocarbon receptor (AhR) and modulate immune re-
sponses (Bjeldanes et al. 1991). AhR ligand TCDD can
induce differentiation of Tregs while inhibiting develop-
ment of Th17 cells, which correlates with increased
methylation and demethylation of the respective promoters
for Foxp3 and IL-17, indicating that epigenetic modifica-
tion can occur upon AhR activation (Singh et al. 2011).
Thus, whereas host epigenetic changes might be induced
by bacteria or nutrients, it is not clear whether a specific
window (early) in life exists or whether it can take place
throughout life.
Future Perspectives
In the last decade, through the development of large-
scale metagenomic technologies, we have gained access
to enormous datasets containing information on microbial
and host genes in health and disease. The future chal-
lenge will be to make sense of these large datasets and
to stratify patient groups according to their genomic or
metabolomic profiles. In addition, modification of the
mucosal immune system through dietary interventions (in
both mothers and infants) requires more in depth
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knowledge on how dietary nutrients or microbial patterns
can alter host immunity (Fig. 2). The fact that fetal life
might not be as devoid of environmental stimulation as
previously thought suggests that modification of the en-
vironment during pregnancy and early life might be able
to (beneficially) alter immunity. Furthermore, epigenetic
modification of the host by bacteria or dietary compo-
nents might be time dependent. Future research should
focus on the question whether host epigenetic modifica-
tion can only be achieved in a specific window (early) in
life or whether changes can be induced lifelong. Rapid
technological advances in this field as evidenced by large
metagenomic screens and epigenetic sequencing plat-
forms will soon provide more answers on these
questions.
In conclusion, environmental factors, such as dietary
components and microbes can shape the mucosal immune
system by influencing differentiation and development of
immune cells and tissues. This in turn influences host
susceptibility towards disease. By using model systems that
can be easily manipulated both genetically and environ-
mentally (i.e., zebrafish and mice) novel pathways can be
discovered that control host responses towards environ-
mental antigens. Elucidation of these conserved pathways
will yield novel targets for nutritional interventions that
will benefit human health.
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